Genentech, Inc. - Product Pipeline Analysis, 2015 Update

Researchmoz added Most up-to-date research on "Genentech, Inc. - Product Pipeline Analysis, 2015 Update" to its huge collection of research reports.

Genentech, Inc. (Genentech) is one of the world's leading biotech companies. The company undertakes research, development, manufacture, and marketing of biotherapeutics. Genentech focuses on developing drugs for unmet medical needs in the areas of cancer, immunological diseases and angiogenic disorders. Some of its major products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis, Xolair, Pulmozyme and Activase. Its research activities focus on areas of cancer, metabolism, immunology, infectious disease and neuroscience. Its clinical development pipeline includes small molecules, monoclonal antibodies, and antibody drug conjugates. The company operates as a wholly owned subsidiary of Roche following its acquisition in 2009. The company is headquartered in South San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

    The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
    The report analyzes all pipeline products in development for the company Genentech, Inc.
    The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
    The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
    The report provides detailed description of products in development, technical specification and functions
    The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=247686

Table of Contents

List of Tables  4
List of Figures  5
Genentech, Inc. Company Snapshot  6
Genentech, Inc. Company Overview  6
Key Information  6
Genentech, Inc. Pipeline Products and Clinical Trials Overview  7
Genentech, Inc. – Pipeline Analysis Overview  10
Business Description  10
Key Facts  10
Genentech, Inc. - Major Products and Services  11
Genentech, Inc. Pipeline Products by Development Stage  13
Genentech, Inc. Pipeline Products Overview  16
Akt Inhibitor Companion Diagnostic Assay  16
Akt Inhibitor Companion Diagnostic Assay Product Overview  16
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay  17
Anti-HER3/EGFR DAF Mab Companion Diagnostic Assay Product Overview  17
Anti-IL17 Mab Companion Diagnostic Assay  18
Anti-IL17 Mab Companion Diagnostic Assay Product Overview  18

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/